Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      FDA approves Bayer AGs Stivarga to treat most common liver cancer

      FDA approves Bayer AG's Stivarga to treat most common liver cancer

      Ruby Khatun Khatun28 April 2017 1:35 PM IST
      The U.S. Food and Drug Administration said on Thursday it has approved Bayer AG's drug Stivarga to treat liver cancer, the first such approval in...
      South Korea fines Novartis 49 million Dollar over kickbacks, suspends insurance payment

      South Korea fines Novartis 49 million Dollar over kickbacks, suspends insurance payment

      Ruby Khatun Khatun28 April 2017 1:32 PM IST
      SEOUL: South Korea said on Thursday it has fined Swiss drug-maker Novartis 55.1 billion won ($48.80 million) for offering doctors kickbacks to...
      Jubilant Life Sciences gets USFDA nod for hypertension drug

      Jubilant Life Sciences gets USFDA nod for hypertension drug

      Ruby Khatun Khatun28 April 2017 10:28 AM IST
      New Delhi: Drug firm Jubilant Life Sciences said it has received final approval from the US health regulator for olmesartan medoxomil tablets, used in...
      Govt rejects Abbott, Medtronic applications to withdraw stents

      Govt rejects Abbott, Medtronic applications to withdraw stents

      Ruby Khatun Khatun27 April 2017 3:29 PM IST
      New Delhi: The government on Wednesday rejected applications by multinational firms Abbott Healthcare Pvt Ltd and India Medtronic Pvt Ltd to withdraw...
      Finance chief quits drugmaker Teva Pharmaceutical, leaving another gap at top

      Finance chief quits drugmaker Teva Pharmaceutical, leaving another gap at top

      Ruby Khatun Khatun27 April 2017 3:19 PM IST
      Teva Pharmaceutical Industries' finance chief Eyal Desheh will step down in the next few months after nearly a decade in the job, the second top...
      3 top hospitals held guilty of reusing Angio Balloon Catheters

      3 top hospitals held guilty of reusing Angio Balloon Catheters

      Ruby Khatun Khatun27 April 2017 3:14 PM IST
      Mumbai: The Food and Drugs Administration (FDA) in a recent inspection found that three city hospitals including Fortis’s hospitals in Mulund,...
      USFDA takes action against 14 companies for selling illegal cancer treatments

      USFDA takes action against 14 companies for selling illegal cancer treatments

      Ruby Khatun Khatun27 April 2017 10:35 AM IST
      The U.S. Food and Drug Administration posted warning letters addressed to 14 U.S.-based companies illegally selling more than 65 products that...
      Alembic Pharmaceuticals gets USFDA nod for anti-hypertension drugs

      Alembic Pharmaceuticals gets USFDA nod for anti-hypertension drugs

      Ruby Khatun Khatun27 April 2017 10:25 AM IST
      New Delhi: Drug firm Alembic Pharmaceuticals has received US health regulator's final approval for two anti-hypertension tablets."The company has...
      E-pharmacy startup Myra Manages funds for expansion in new markets

      E-pharmacy startup Myra Manages funds for expansion in new markets

      Ruby Khatun Khatun27 April 2017 10:22 AM IST
      Bengaluru: Myra Medicine, a Bengaluru based online pharmacy, promising doorstep delivery of medicines in 30 minutes with 15 per cent discount has...
      Drug price Control adversely impacting Pharma Industry: K Satish Reddy

      Drug price Control adversely impacting Pharma Industry: K Satish Reddy

      Ruby Khatun Khatun27 April 2017 10:15 AM IST
      HYDERABAD, APRIL 21: A national seminar on bulk drug and pharma industry was organised by the Bulk Drug Manufacturers Association-India (BDMA-I) to...
      Japans Otsuka aims to apply for TB drug approval in India in 90 days

      Japan's Otsuka aims to apply for TB drug approval in India in 90 days

      Ruby Khatun Khatun26 April 2017 5:20 PM IST
      Mumbai: Japanese drug maker Otsuka Pharmaceutical aims to apply for approval of its tuberculosis (TB) drug delamanid in India within three months, a...
      Serum Institute buys polio vaccine co in Czech for 72 million euros

      Serum Institute buys polio vaccine co in Czech for 72 million euros

      Ruby Khatun Khatun26 April 2017 1:12 PM IST
      Mumbai: Serum Institute of India today acquired the defunct unit in Czech of Florida-based Nanotherapeutics that makes injectable polio doses for 72...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok